FDA Bans Indian Pharmaceutical Firm From Exporting To US Because Of Quality Control Issues.

The Wall Street Journal (3/26, 5.67M) reported in its “Pharmalot” blog that the FDA banned the import of medicines from India-based pharmaceutical firm Aarti Drugs after it failed an FDA inspection last August. The agency’s inspection followed a warning letter the company received the previous year over several manufacturing standard violations at two Aarti facilities during a 2012 inspection. The plant is one of several from India that have faced similar bans.